These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 24894658)

  • 1. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.
    Kuchen T; Straumann A; Safroneeva E; Romero Y; Bussmann C; Vavricka S; Netzer P; Reinhard A; Portmann S; Schoepfer AM
    Allergy; 2014 Sep; 69(9):1248-54. PubMed ID: 24894658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
    Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
    Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
    Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
    Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
    von Arnim U; Malfertheiner P
    Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.
    Moawad FJ; Veerappan GR; Dias JA; Baker TP; Maydonovitch CL; Wong RK
    Am J Gastroenterol; 2013 Mar; 108(3):366-72. PubMed ID: 23399553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.
    Schlag C; Pfefferkorn S; Brockow K; Haller B; Slotta-Huspenia J; Schulz S; von Werder A; Ring J; Schmid RM; Bajbouj M
    J Clin Gastroenterol; 2014 Aug; 48(7):600-6. PubMed ID: 24177377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined and Alternating Topical Steroids and Food Elimination Diet for the Treatment of Eosinophilic Esophagitis.
    Reed CC; Safta AM; Qasem S; Angie Almond M; Dellon ES; Jensen ET
    Dig Dis Sci; 2018 Sep; 63(9):2381-2388. PubMed ID: 29380175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
    Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
    United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
    Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
    Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
    Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.
    Schoepfer A; Safroneeva E; Straumann A
    Dig Dis; 2016; 34(5):462-8. PubMed ID: 27333298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis.
    Katzka DA; Tadi R; Smyrk TC; Katarya E; Sharma A; Geno DM; Camilleri M; Iyer PG; Alexander JA; Buttar NS
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1824-9.e1. PubMed ID: 24681080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
    Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
    Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis.
    Runge TM; Eluri S; Woosley JT; Shaheen NJ; Dellon ES
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 29206905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive factors of eosinophilic esophagitis in esophageal food bolus impaction].
    Rodríguez-Sánchez J; López Viedma B; Verdejo Gil C; Martín Dávila F; Hernández Albujar A; Lorente Poyatos R; de La Santa Belda E; Martín Escobedo LR; Olmedo Camacho J
    Rev Gastroenterol Mex; 2013; 78(1):5-11. PubMed ID: 23374542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients.
    Straumann A; Bussmann C; Zuber M; Vannini S; Simon HU; Schoepfer A
    Clin Gastroenterol Hepatol; 2008 May; 6(5):598-600. PubMed ID: 18407800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
    Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
    Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort.
    Lieberman JA; Morotti RA; Konstantinou GN; Yershov O; Chehade M
    Allergy; 2012 Oct; 67(10):1299-307. PubMed ID: 22913672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management guidelines of eosinophilic esophagitis in childhood.
    Papadopoulou A; Koletzko S; Heuschkel R; Dias JA; Allen KJ; Murch SH; Chong S; Gottrand F; Husby S; Lionetti P; Mearin ML; Ruemmele FM; Schäppi MG; Staiano A; Wilschanski M; Vandenplas Y;
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):107-18. PubMed ID: 24378521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
    Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
    Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.